blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1214427

EP1214427 - 26176, A NOVEL CALPAIN PROTEASE AND USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.11.2006
Database last updated on 11.09.2024
Most recent event   Tooltip24.11.2006Application deemed to be withdrawnpublished on 27.12.2006  [2006/52]
Applicant(s)For all designated states
MILLENNIUM PHARMACEUTICALS, INC.
75 Sidney Street Cambridge
Massachusetts 02139 / US
[N/P]
Former [2002/25]For all designated states
Millennium Pharmaceuticals, Inc.
75 Sidney Street
Cambridge, Massachusetts 02139 / US
Inventor(s)01 / KAPELLER-LIBERMANN, Rosana
86 Beacon Street
Chestnut Hill, MA 02467 / US
02 / WILLIAMSON, Mark
15 Stonecrest Drive
Saugus, MA 01906 / US
 [2002/25]
Representative(s)Woods, Geoffrey Corlett
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2002/25]Woods, Geoffrey Corlett
J.A. KEMP & CO. Gray's Inn 14 South Square
London WC1R 5JJ / GB
Application number, filing date00963341.308.09.2000
[2002/25]
WO2000US24790
Priority number, dateUS1999039218909.09.1999         Original published format: US 392189
[2002/25]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0118216
Date:15.03.2001
Language:EN
[2001/11]
Type: A2 Application without search report 
No.:EP1214427
Date:19.06.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 15.03.2001 takes the place of the publication of the European patent application.
[2002/25]
Search report(s)International search report - published on:EP07.02.2002
ClassificationIPC:C12N15/57, C12N9/64, C12N1/21, C12N5/10, C07K16/40, C12Q1/37, C12Q1/68, A61K38/48
[2002/25]
CPC:
C12N9/6472 (EP,US); A61K38/00 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/25]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:26176, EINE CALPAINPROTEASE UND VERWENDUNG DAVON[2002/25]
English:26176, A NOVEL CALPAIN PROTEASE AND USES THEREOF[2002/25]
French:NOUVELLE PROTEASE CALPAINE 26176 ET UTILISATIONS[2002/25]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase04.04.2002National basic fee paid 
04.04.2002Designation fee(s) paid 
04.04.2002Examination fee paid 
Examination procedure05.04.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
04.04.2002Examination requested  [2002/25]
10.06.2002Amendment by applicant (claims and/or description)
22.07.2004Despatch of a communication from the examining division (Time limit: M06)
28.01.2005Reply to a communication from the examining division
04.04.2005Despatch of a communication from the examining division (Time limit: M06)
14.10.2005Reply to a communication from the examining division
13.02.2006Despatch of a communication from the examining division (Time limit: M04)
26.06.2006Application deemed to be withdrawn, date of legal effect  [2006/52]
31.07.2006Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2006/52]
Fees paidRenewal fee
04.04.2002Renewal fee patent year 03
12.09.2003Renewal fee patent year 04
23.09.2004Renewal fee patent year 05
21.09.2005Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.09.200607   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]DE19737105  (BASF AG [DE]);
 [A]EP0799892  (TAKEDA CHEMICAL INDUSTRIES LTD [JP])
 [X]  - FRANZ TANNA ET AL, "Capn7: A highly divergent vertebrate calpain with a novel C-terminal domain.", MAMMALIAN GENOME, (199903), vol. 10, no. 3, ISSN 0938-8990, pages 318 - 321, XP001002538 [X] 1-23 * the whole document *

DOI:   http://dx.doi.org/10.1007/s003359900995
    [ ] - EMBL, (19990501), XP002168668 [ ] * abstract *
 [X]  - FUTAI E ET AL, "Molecular cloning of Pa1BH, a mammalian homologue of the Aspergillus atypical calpain Pa1B.", EMBL, (19990615), XP002168481 [X] 1-23 * abstract *
 [X]  - "National Cancer Institute, Cancer Genome Anatomy Project", EMBL, (19970421), XP002168482 [X] 1-23 * abstract *
 [X]  - "National Cancer Institute, Cancer Genome Anatomy Project", EMBL, (19980818), XP002168483 [X] 1-23 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.